Hepatitis C Treatment Info

[Guest guest]

HIVandHepatitis.comHIVandHepatitis.comnewsletter@...

IAS 2011: Boceprevir Response Differs According to HCV

Genotype 1 SubtypePeople with

hepatitis C virus (HCV) genotype 1b respond better to

boceprevir and are less likely to develop drug resistance

than those with genotype 1a, according to study findings

reported last week at the 6th International AIDS Society

Conference on HIV Pathogenesis, Treatment and Prevention

in Rome.PSI-7977 plus Standard Therapy Cures 100% of

Genotype 2-3 Hepatitis C PatientsPharmasset's

investigational hepatitis C virus (HCV) polymerase inhibitor

PSI-7977 combined with pegylated interferon/ribavirin

cured 100% of people with HCV genotype 2 and 3 in the

Phase 2b PROTON trial; sustained response results for

hard-to-treat genotype 1 patients are expected later this

year.

[Guest guest]

HIVandHepatitis.comHIVandHepatitis.comnewsletter@...

IAS 2011: Boceprevir Response Differs According to HCV

Genotype 1 SubtypePeople with

hepatitis C virus (HCV) genotype 1b respond better to

boceprevir and are less likely to develop drug resistance

than those with genotype 1a, according to study findings

reported last week at the 6th International AIDS Society

Conference on HIV Pathogenesis, Treatment and Prevention

in Rome.PSI-7977 plus Standard Therapy Cures 100% of

Genotype 2-3 Hepatitis C PatientsPharmasset's

investigational hepatitis C virus (HCV) polymerase inhibitor

PSI-7977 combined with pegylated interferon/ribavirin

cured 100% of people with HCV genotype 2 and 3 in the

Phase 2b PROTON trial; sustained response results for

hard-to-treat genotype 1 patients are expected later this

year.

[Guest guest]

HIVandHepatitis.comHIVandHepatitis.comnewsletter@...

IAS 2011: Boceprevir Response Differs According to HCV

Genotype 1 SubtypePeople with

hepatitis C virus (HCV) genotype 1b respond better to

boceprevir and are less likely to develop drug resistance

than those with genotype 1a, according to study findings

reported last week at the 6th International AIDS Society

Conference on HIV Pathogenesis, Treatment and Prevention

in Rome.PSI-7977 plus Standard Therapy Cures 100% of

Genotype 2-3 Hepatitis C PatientsPharmasset's

investigational hepatitis C virus (HCV) polymerase inhibitor

PSI-7977 combined with pegylated interferon/ribavirin

cured 100% of people with HCV genotype 2 and 3 in the

Phase 2b PROTON trial; sustained response results for

hard-to-treat genotype 1 patients are expected later this

year.

[Guest guest]

HIVandHepatitis.comHIVandHepatitis.comnewsletter@...

IAS 2011: Boceprevir Response Differs According to HCV

Genotype 1 SubtypePeople with

hepatitis C virus (HCV) genotype 1b respond better to

boceprevir and are less likely to develop drug resistance

than those with genotype 1a, according to study findings

reported last week at the 6th International AIDS Society

Conference on HIV Pathogenesis, Treatment and Prevention

in Rome.PSI-7977 plus Standard Therapy Cures 100% of

Genotype 2-3 Hepatitis C PatientsPharmasset's

investigational hepatitis C virus (HCV) polymerase inhibitor

PSI-7977 combined with pegylated interferon/ribavirin

cured 100% of people with HCV genotype 2 and 3 in the

Phase 2b PROTON trial; sustained response results for

hard-to-treat genotype 1 patients are expected later this

year.